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ABSTRACT! 
Objective: The objective of this evidence based medicine review is to determine whether 
or not soy-based proteins, meals, and diets are effective treatments in reducing waist 
circumference in overweight and obese adults ages 20-75 years. 
Study design: Review of three published, randomized controlled trials (RCTs) published 
in 2003, 2007, and 2011. All English language. 
Data Source: The three randomized controlled trials that used in this review were found 
using PubMed. 
Outcomes measured: The outcomes measured were improvement of patient’s 
overweight and obesity status and their overall quality of life through the indication of 
reduced waist circumference. By measuring patient’s waist circumference before, during, 
and after treatment of soy-based proteins, meals, and diets with measurement methods 
between the lower rib and iliac crest at the level of the navel, a non-distensible tape 
measure, and an inelastic scale. 
Results: In a RCT by Allison et al. (2003), soy-based meal replacement formula reduced 
waist circumference for overweight and obese adults in a 12 weeks period with an 
estimate treatment effectiveness of P <0.001 as a result. In a RCT by Liao et al. (2007), 
soy-based diet reduced waist circumference for overweight and obese adults in a 8 weeks 
period with an estimate treatment effectiveness of 95% CI 1.6-2.8 as a result. In a RCT 
by Takahira et al. (2011), soy protein reduced waist circumference for overweight and 
obese adults in a 20 weeks period with an estimate treatment effectiveness of P<0.05 as a 
result. 
Conclusions: The result of all three randomized controlled trials suggest that soy-based 
proteins, meals, and diets, as a form of treatment for reduction in waist circumference is 
effective in regards of patient’s overweight and obesity status and their overall quality of 
life. This topic does warrant additional research. Further studies conducted should 
include if patient needs a post-life-long maintain diet with soy-based proteins and meals 
after they have achieve a normal BMI waist circumference. In addition, will this be 
available for patients with mild soy-allergy, but controlled with anti-histamines.  
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Introduction 
 
 Overweight and obesity are chronic conditions defined by the BMI of a patient.1 
This paper evaluates three randomized controlled trials (RCTs) comparing the efficacy of 
soy-based proteins, meals, and diets as an add-on regimen for the treatment of reducing 
waist circumference in overweight and obese adults ages 20-75 years. 
 Obesity affects more than one-third of U.S adult, which is about 36.5%.2 Obesity 
is a risk factor for other major chronic diseases including type 2 diabetes mellitus, 
coronary artery diseases, osteoarthritis, and stroke, which can lead to a detrimental 
impact on the patient’s quality of life. 2 The annual medical cost of obesity in the U.S was 
estimated to $147 billion in 2008 and continues to increase annually.1, 3 There are 928.6 
million reporting of health care visit treatment for obesity, which is about 54.6% on 
average visits to the primary care physician. 3 Everyday both physician assistants and 
physicians are working to treat and control obesity in their patients, with the goal to 
improve quality of life and limit risk factors for major chronic diseases. 
 Obesity is a state of excess adipose tissue mass.4 Obesity is a result of behavioral 
and genetic factors. Behaviors factors include: dietary food choices, lack of physical 
activities, medication use, economic status, and education.4 Genetic factors include: 
hypothyroidism, type 1 diabetes mellitus, polycystic ovary syndrome, and leptin 
abnormalities.4 
 Obesity is sufficiently diagnostic through physical examination in detecting 
excess body fat in conjunction with a more quantitative evaluation, the BMI.4 The BMI 
correlates with excess adipose tissue by the measurement of body weight in kilograms by 
the height in meters squared.4 The BMI classification are as followed: normal BMI as 
18.5–24.9, overweight BMI as 25–29.9, class I obesity BMI as 30–34.9, class II obesity 
BMI as 35–39.9, and class III (extreme) obesity BMI as greater than 40.4  
 There are multiple treatments available for obesity. The initial treatment for 
obesity is diet modifications: lowering caloric intake (800–1000 kcal/day), lowering the 
amount of sugar and fat in the diet, and increase physical activities daily (at least 1 hour 
of exercise a day). 4 Over the counter medications or prescription medications can be used 
as a conjunction as well as an alterative treatment when patient fails diet modifications. 
Catecholaminergic medications are approved for short-term use such as: phentermine, 
diethylpropion, benzphetamine, and phendimetrazine.3, 4 Long-term medications include 
orlistat.3, 4 In 2014, the FDA approved other alternative medications for weight loss 
including liraglutide and combination of bupropion and naltrexone drugs.3, 4 In severe 
cases of obesity (BMI >40 or BMI >35 with significant co-morbidities) bariatric surgery 
is an alternative option.4 Bariatric surgery include: Roux-en-Y gastric bypass (RYGB), 
vertical banded gastroplasty, and sleeve gastrectomy.4 
 The treatments available such as: diets, exercise, over the counter medications, 
prescription medications, and surgeries are effective for overweight and obesity patients; 
however, the thought of using soy-based proteins, meals, and diets can be another option 
or add-on regimen to help improve diet modifications to decrease waist circumference 
and the overall health status of overweight and obesity adults’ ages 20-75 years.  
 
Objective 
 The objective of this selective EBM review is to determine whether or not “Are 
soy-based proteins, meals, and diets an effective treatment in reducing waist 
circumference in overweight and obese adults ages 20-75 years?”  
 
Methods 
 The investigation chosen in these three randomized controlled trials (RCTs) are 
reduction of waist circumferences due to soy-based proteins, meals, and diets. The 
selection of the studies is based on the target population, interventions used to compare 
control group and experimental group, and the outcomes measured. The target population 
was limited to overweight and obese adults between the ages of 20-75 years. The 
intervention of interest used for participants was soy-based proteins, meals, and diets.5, 6, 7 
The experimental group was put on soy-based proteins, meals, and diets, while the 
control group was put on a non-soy-based proteins, meals, and diets.5, 6, 7 Outcomes were 
based on measurement methods between the lower rib and iliac crest at the level of the 
navel, a non-distensible tape measure, and an inelastic scale.5, 6, 7 Three randomized 
controlled trials (RCTs) were used in this type of study to further answer the investigation 
of soy-based proteins, meals, and diets as a treatment option for reducing waist 
circumference in overweight and obese adults ages 20-75 years.  
 Key words soybean proteins and obesity were searched using the following search 
engines: PubMed and Cochrane Database. Articles selected were written in the English 
language, peer-reviewed journals, and published in 2003, 2007, and 2011 and had not 
been previously used in a systematic review or meta-analysis. Inclusion criteria for these 
studies were RCTs that were published after 1996 based on their relevance and 
importance of the outcome to the patient (Patient Oriented Evidence That Matters, 
POEMS) and that investigated the effectiveness of soy-based proteins, meals, and diets as 
a treatment option for reducing waist circumference in overweight and obese adults 
(Table 1). Exclusion criteria consisted of studies that investigated patients who were not 
considered overweight or obese adults who are under 20 or over 75 years old. Statistics 
were reported using p values, standard deviation, and mean change from baseline.  
Table 1- Demographics and Characteristics of included studies 5,6,7 
Study Type # 
Pts 
Age 
(yrs
) 
Inclusion 
Criteria 
Exclusion 
Criteria 
W/
D 
Interventions 
Allison 
DB, 
Gadbury 
G, 
Schwart
z LG, 
2003 
(1) 
RCT 100 35-
65 
 
Patients 
with BMI 
of 28-41, 
ages 35-65, 
and 
medically 
fit for safe 
weight loss 
through a 
physical 
exam. 
Patients with 
weight loss 
>5kg in the 
past 3 months, 
use weight loss 
medication 
within the past 
6 wks, BMI > 
90th percentile, 
and any 
medical or 
psychological 
contradictions. 
25 
 
Randomize meal 
replacement 
treatment group: 
5 Scan Diet 
Shakes,1200kcal
=day) or control 
group: 
1200kcal=day.  
Both received 
dietary 
counseling for 
weight loss and 
followed 12wks. 
Liao FH, 
Shieh 
MJ, 
Yang 
SC, Lin 
SH, 
Chien 
YW 
2007 
(2) 
RCT  30 20–
60 
Patients 
with BMI 
29-30, ages 
20-60. 
 
Patient with 
history of: 
CVD, kidney 
disease, DM, 
and females 
who are 
pregnant or 
breastfeeding. 
0 Soy-based low-
calorie group 
consumed only 
soy protein and 
traditional low-
calorie group 
consumed 2/3 
animal proteins 
and 1/3 plant 
protein in 1200 
kcal/d 8wks diet. 
Anthropometric 
data recorded 
every week and 
biochemical data 
before and after 
8wks compared. 
Takahira 
M, Noda 
K, 
Fukushi
ma M, 
2011 
(3) 
RCT 48 22– 
72 
Patients 
ages 20-75 
with 
visceral fat 
area ≥ 100 
cm2 and 
able to 
consume 
Patients with 
2nd obesity, 
DM, CVD, 
kidney or GI or 
thyroid 
disease, stroke, 
pregnancy, 
breastfeeding, 
0 Trial formula 
(SP) and control 
formula (MP) 
given for 20 wks. 
Each contains 
170kcal/pack. 
Patients recorded 
by: food and 
formula 
shakes. 
and substance 
abuse. 
drink intake for 3 
days before their 
visits on weeks: 
0, 12, and 20.  
 
Outcomes Measured 
 The outcomes measured were improvement of patient’s overweight and obesity 
status indicated by waist circumference reduction in hoping this is the first step 
improving their overall quality of life. The patient’s waist circumferences were measured 
before, during, and after treatment of soy-based proteins, meals, and diets. Allison et al. 
(2003) measured waist circumference with a non-distensible tape measure.5 Liao et al. 
(2007) measured waist circumference with an inelastic scale.6 Takahira et al. (2011) 
measured waist circumference between the lower rib and iliac crest at the level of the 
navel with a tape measure.7  
 
Results 
 
 In the study done by Allison et al. (2003), the reported statistics compared soy-
based meal replacement formula as the experimental group with single session of dietary 
counseling and a pamphlet describing good weight loss practices as the control group in a 
12 weeks period. The results of waist circumference reduction for soy-based meal 
replacement formula (n=50) and control group (n=50) where recorded as a mean ± 
standard deviation at baseline within a 12 weeks period (Table 2). 5 The results of soy-
based meal replacement formula and control group were evaluated in a 12 weeks period 
with an estimate treatment effectiveness of P <0.003 and standard deviation 4.2.5 
Table 2: Intention-to-treat analysis of waist circumference: change, mean ±SD 5 
Study Period Treatment, Mean (s.d.) Control, Mean (s.d.) P-value 
4 weeks -3.2 (4.0) -2.9 (4.0)  0.553  
8 weeks -5.4 (4.5) -3.9 (8.3)  0.324  
12 weeks -6.0 (4.2) -2.9 (3.7) 0.003 
 
 In the study done by Liao et al. (2007), the reported statistics compared soy low-
calorie diet as the experimental group with traditional low-calorie diet as the control 
group in a 8 weeks period.6 The results of waist circumference reduction for soy low-
calorie diet (n=15) and control group (n=15) where recorded as mean ± standard 
deviation at baseline within a 8 weeks period (Table 3). 6 The treatment effect between 
the soy low-calorie diet and control group were evaluated in a 8 weeks period with an 
estimate treatment effectiveness of mean change from baseline: -2.5±3.5, P < 0.05, and 
95% Confidence Interval (CI) 1.6-2.8, as a result.6 
Table 3: Intention-to-treat analysis of waist circumference (cm): change, mean ±SD 6 
Soy group Traditional group 
Beginning End Change Beginning End Change 
87.3 ± 11.0 84.8 ± 10.3a -2.5 ± 3.5 90.2 ± 13.7 87.3 ±12.3a -2.9 ± 3.3 
 
 In the study done by Takahira et al. (2011), the reported statistics compared soy 
protein as the experimental group with milk protein as the control group in a 20 week 
period.7 The results of waist circumference reduction for soy protein and control group 
where recorded as mean ± standard deviation at baseline, 95% Confidence Interval (CI), 
and p-value of a 20 weeks period (Table 4 and Table 5). 7 The treatment effect between 
the soy protein and control group was evaluated in a 20 weeks period with an estimate 
treatment effectiveness of P <0.05 and mean change from baseline: -2.2 ± 0.5, as a 
result.7 
Table 4: Intention-to-treat analysis of waist circumference (cm): change, mean ±SD 7 
Soy protein group Milk protein group 
0 weeks 12 weeks 20 weeks 0 weeks 12 weeks 20 weeks 
98.1 ± 2.1 97.0 ± 2.1 95.4 ± 1.9 98.1 ± 1.8 96.6 ± 1.8 96.1 ± 1.7 
(–1.7 ± 0.6) (–2.2 ± 0.5) (–1.5 ± 0.5) (–2.0 ± 0.7) 
 
Table 5: Intention-to-treat analysis of waist circumference (cm): CI and P-value 7 
Estimate (95% CI) P value 
–0.003 
(–0.009 to 0.003) 
0.3446 
 
 In these three randomized controlled trials (RCTs), the experimental groups were 
soy-based proteins, meals, and diets and the control groups were non-soy based products 
and diet plans. Each study had specific tolerability and adverse events. In the study done 
by Allison et al. (2003), five subjects withdrew from the study due to adverse events: 
three subjects experienced diarrhea, one subject experienced gastric reflux, and one 
subject experienced generic ‘symptoms unbear- able’). 5 In the study done by Liao et al. 
(2007), there were no reports of withdrawal or adverse effects when study was conducted 
of all thirty subjects.6 In the study done by Takahira et al. (2011), there were no reports of 
withdrawal or adverse effects when study was conducted of all forty-eight subjects.7 
Discussion 
 The results from all three randomized controlled trials Allison et al. (2003), Liao 
et al. (2007), and Takahira et al. (2011) suggest soy-based proteins, meals, and diets have 
been effective in reducing waist circumference for overweight and obese adults ages 20-
75 years, which respectively help improve patient’s overweight and obesity status and 
possibly the first step in improving their overall quality of life. However, soy is not well-
known for treating obesity and reducing waist circumferences. Soy is well-known for an 
add-on treatment for diseases including: breast cancer, prostate cancer, cardiovascular 
disease, and reduction of bone fractures due to bioactive components of saponins, 
protease inhibitors, phytic acid, and isoflavone.8 Since soy is inexpensive and seen in 
many everyday products as an add-on ingredient; it is not difficult for patients to use soy 
routinely as an add-on diet to reduce waist circumference, patient’s overweight and 
obesity status as well as improving their overall quality of life. 
 The relatively new concept of using soy-based proteins, meals, and diets as an 
add-on regimen to reduce waist circumference for overweight and obese adults has its 
limitations due to its original use of treating other diseases such as: breast cancer, prostate 
cancer, cardiovascular disease, and reduction of bone fractures.8 Major limitations in 
these three randomized controlled trials studies were small study size groups and short 
experimental time frame which made long-term effects of treatment inconclusive. In the 
study done by Allison et al. (2003), there were 100 participants in a 12 weeks 
experimental period; as the study states due to limited durations the long-term effects of 
the treatment on study outcomes were not evaluated.5 In the study done by Liao et al. 
(2007) there were 30 participants in an 8 weeks experimental period and the study done 
by Takahira et al. (2011) there were 48 participants in a 20 weeks experimental period; 
although these studies were successful in reporting statically the reduction of waist 
circumference by using soy-low calorie diet and soy protein it did not discuss long-term 
effects of treatment due to limited durations of study period.6,7   
 
Conclusion 
 In conclusion, there are statistical evidences suggesting soy-based proteins, meals, 
and diets as an add-on regimen for reducing waist circumference in overweight and obese 
adults ages 20-75 years is an effective treatment indicated in three randomized controlled 
trials Allison et al. (2003), Liao et al. (2007), and Takahira et al. (2011), 5, 6, 7 Although 
each of these studies has a relatively small sample size group and short-experimental 
duration, the results found were still considered statistical significant in favor of soy-
based proteins, meals, and diets as an add-on regimen for the treatment. However, all 
three studies could have had larger sample sizes and longer-experimental duration to 
provide stronger evidence that soy-based proteins, meals, and diets as an add-on regimen 
is effective for both short-term and long-term use without severe complications or 
adverse effects in reducing waist circumference. Future study is warranted to evaluate if 
patient needs a lifetime maintain diet with soy-based proteins and meals after they have 
achieve a normal BMI waist circumference.  
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